Mind the Gap! Lay and Medical Perceptions of Risks Associated with the Use of Alternative Treatment and Conventional Medicine

Complementary Medicine Research

Volumn 22, Issue 1, 2015, Pages 24-29

  Salamonsen, Anita ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Cancer; Complementary and alternative medicine; Decision making; Doctor patient communication; Multiple sclerosis; Norway; Patient safety; Risk perceptions

Indexed keywords

ADULT; AGED; ALTERNATIVE MEDICINE; ATTITUDE TO HEALTH; DOCTOR PATIENT RELATION; EDUCATION; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; MEDICINE; MIDDLE AGED; PERCEPTION; RISK; STANDARDS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; COMPLEMENTARY THERAPIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICINE; MIDDLE AGED; PERCEPTION; PHYSICIAN-PATIENT RELATIONS; RISK;

EID: 85001740613     PISSN: 25042092     EISSN: 25042106     Source Type: Journal    
DOI: 10.1159/000376555     Document Type: Article

References (50)

1. Chung E, Horwitz JR, Pottow JAE, Jagsi R: Malpractice suits and physician apologies in cancer care. J Oncol Pract 2011; 7: 389-393.
2. Gabe J: Health, medicine and risk: the need for a sociological approach; in Gabe J (ed): Medicine, Health and Risk. Sociological Approaches. Oxford, Blackwell, 1996, pp 1-17.
3. Davis EM: Risky business: medical discourse, breast cancer, and narrative. Qual Health Res 2008; 18: 65-76.
4. Slovic P: Introduction and overview; in Slovic P (ed): The Feeling of Risk. New Perspectives on Risk Perception. London, Earthscan, 2010, pp x-xxvii.
5. Slovic P: Trust, emotion, sex, politics, and science: surveying the risk-assessment battlefield. Risk Anal 1999; 19: 689-701.
6. Aven T, Renn O: On risk defined as an event where the outcome is uncertain. J Risk Res 2009; 12: 1-11.
7. Wardle J, Adams J: Indirect risks of complementary and alternative medicine; in Adams J, Andrews GJ, Barnes J, Broom A, Magin P (eds): Traditional, Complementary and Integrative Medicine. Hampshire, Palgrave Macmillan, 2012, pp 212-219.
8. Slovic P: The Perception of Risk. London, Earthscan, 2000.
9. Peters E, Hibbard J, Slovic P, Dieckmann N: Numerancy skill and the communication, comprehension and use of risk-benefit information; in Slovic P (ed): The Feeling of Risk. New Perspectives on Risk Perception. London, Earthscan, 2010, pp 345-352.
10. Taylor-Gooby P, Zinn J: The current significance of risk; in Taylor-Gooby P, Zinn J (eds): Risk in Social Science. Oxford, Oxford University Press, 2006, pp 1-19.
11. Lovdata: Act No. 64 of 27 June 2003 relating to alternative treatment of disease, illness, etc. www.regjeringen. no/globalassets/upload/kilde/hod/red/2005/0076/ddd/ pdfv/242593-regulations-no-1501-forskr-alt.behandl-.pdf (access 29.01.2015).
12. Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M: How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 2012; 11: 187-203.
13. Skovgaard L, Halkier Nicolaisen P, Pedersen E, Kant M, Fredrikson S, Verhoef M, Meyrowitsch DW: Use of complementary and alternative medicine among people with multiple sclerosis in the Nordic MS societies. Autoimmune Dis 2012; 2012: 841085.
14. Bowling AC, Ibrahim R, Stewart JD: Alternative medicine and multiple sclerosis: an objective review from an American perspective. International Journal of MS Care 2000; 2: 15-28.
15. Bowling AC, Stewart TM: Current complementary and alternative therapies for multiple sclerosis. Curr Treat Options Neurol 2003; 5: 55-68.
16. Bowling AC: Complementary and Alternative Medicine and Multiple Sclerosis. New York, Demos Medical Publishing, 2007.
17. Pedersen IK: 'It can do no harm': body maintenance and modification in alternative medicine acknowledged as a non risk health regimen. Soc Sci Med 2013; 90: 56-62.
18. Wesselius T, Heersema, DJ, Mostert JP, Heerings, M, Admiraal-Behloul F, Talebian A, van Buchem MA, De Keyser J: A randomized crossover study of bee sting therapy for multiple sclerosis. Neurology 2005; 65: 1764-1768.
19. Brandenberger M, Simões-Wüst AP, Rostock M, Rist L, Saller R: An exploratory study on the quality of life and individual coping of cancer patients during mistletoe therapy. Integr Cancer Ther 2011; 11: 90-100.
20. Risberg T, Kolstad A, Bremnes Y, Holte H, Wist EA, Mella O, Klepp O, Wilsgaard T, Cassileth BR: Knowledge of and attitudes toward complementary and alternative therapies: a national multicentre study of oncology professionals in Norway. Eur J Cancer 2004; 40: 529-535.
21. Salamonsen A, Drageset BJ, Fønnebø V: A patientdefined 'best case' of multiple sclerosis related to the use of complementary and alternative medicine. Glob Adv Health Med 2012; 1: 30-32.
22. Breisameter C: Medical decision-making and communication of risks: an ethical perspective. J Med Ethics 2010; 36: 349-352.
23. Han E, Johnson N, DelaMelena T, Glissmeyer M, Steinbock K: Alternative therapy used as primary treatment for breast cancer negatively impacts outcomes. Ann Surg Oncol 2011; 18: 912-916.
24. Pucci E, Cartechini E, Taus C, Giuliani G: Why physicians need to look more closely at the use of complementary and alternative medicine by multiple sclerosis patients. Eur J Neurol 2004; 11: 263-267.
25. Esmonde L, Long AF: Complementary therapy use by persons with multiple sclerosis: benefits and research priorities. Complement Ther Clin Pract 2008; 14: 176-184.
26. Zanella SG, Roberti di Sarsina P: Personalization of multiple sclerosis treatments: using the chelation therapy approach. Explore (NY) 2013; 9: 244-248.
27. Tjon Eng Soe SH, Kopsky DJ, Jongen PHJ, de Vet HCW, Oei-Tan CL: Multiple sclerosis patients with bladder dysfunction have decreased symptoms after electro-acupuncture. Mult Scler 2009; 15: 1376-1377.
28. Salamonsen A, LaunsüsL, Kruse T, Eriksen, SH: Understanding unexpected courses of multiple sclerosis among patients using complementary and alternative medicine: a travel from recipient to explorer. Int J Qual Stud Health & Well-being 2010; 5: 5032.
29. Salamonsen A, Kruse T, Eriksen, SH: Modes of embodiment in breast cancer patients using complementary and alternative medicine. Qual Health Res 2012; 22: 1497-1512.
30. Salamonsen, A: Doctor-patient communication and cancer patients' choice of alternative therapies as supplement or alternative to conventional care. Scand J Car Sci 2013; 27: 70-76.
31. Fønnebø V, Drageset BJ, Salamonsen A: The NAFKAM International Registry of Exceptional Courses of Disease related to the use of complementary and alternative medicine. Glob Adv Health Med 2012; 1: 7-9.
32. LaunsüsL, Drageset BJ, Fønnebø V, Jacobson JS, Haahr N, White JD, Salamonsen A, Horneber M, Egeland E: Exceptional disease courses after the use of CAM: selection, registration, medical assessment, and research. An international perspective. J Altern Complement Med 2006; 12: 607-613.
33. Norman I, Redfern S, Tomalin D, Oliver S: Developing Flanagan's critical incident technique to elicit indicators of high and low quality nursing care from patients and their nurses. J Adv Nurs 1992; 17: 590-600.
34. Patton MQ: Qualitative Research and Evaluation Methods, ed 3. Thousand Oaks, Sage, 2002.
35. Salamonsen A: Exploring 'exceptional' or unusual courses of disease: methodology and learning outcomes; in Brindle P (ed): SAGE Research Methods Cases. London, Sage, 2014, pp 1-23.
36. Gobo G: Re-conceptualizing generalization: old issues in a new frame; in Alasuutari P, Bickman L, Brannen J (eds): The SAGE Handbook of Social Research Methods. London, Sage, 2004, pp 193-213.
37. Bryman A: Social Research Methods. Oxford, Oxford University Press, 2000.
38. Lublin FD, Reingold SC: Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-911.
39. Kvale S: Interviews. An Introduction to Qualitative Research Interviewing. Thousand Oaks, California, Sage, 1996.
40. Minichiello V, Aroni R, Timewell E, Alexander L: Indepth Interviewing. Researching People. Melbourne, Longman Cheshire, 1990.
41. Hsieh HF, Shannon SE: Three approaches to qualitative content analysis. Qual Health Res 2005; 15: 1277-1288.
42. World Medical Association (WMA): Declaration of Helsinki. Code of Ethics 1964 (revised). Edinburgh, 2000.
43. Rose K: Unstructured and semi-structured interviewing. Nurse Researcher 1994; 1: 23-32.
44. Stub T, Salamonsen A, Kristoffersen A, Musial, F: How to handle worsening of condition during treatment - risk assessment in homeopathic practice. Forsch Komplementmed 2015; 1:DOI 10.1159/000377644.
45. Slovic P, Finucane M, Peters E, MacGregor DG: Risk as analysis and risk as feelings: some thoughts about affect, reason, risk and rationality; in Slovic P (ed): The Feeling of Risk. New Perspectives on Risk Perception. London, Earthscan, 2010, pp 21-50.
46. Fox N, Ward K: Health identities: from expert patient to resisting consumer. Health 2006; 10: 461-479.
47. Slovic P, Peters E, Finucane ML, MacGregor DG: Affect, risk, and decision making. Health Psychol 2005; 24(suppl 4):35-40.
48. Prior L: Belief, knowledge and expertise: the emergence of the lay expert in medical sociology. Sociol Health Ill 2003; 25: 41-57.
49. Fønnebø V, Drageset BJ, Salamonsen A: Worst cases reported to the NAFKAM International Registry of Exceptional Courses of Disease. Glob Adv Health Med 2012; 1: 30.
50. Sandaunet AG, Salamonsen A: CFS patients' different experiences with Lightning Process (in Norwegian). Sykepleien Forskning 2012; 7: 262-268.